Oncolytic Virus Immunotherapy Market

1    Preface
2    Scope and Methodology
2.1    Objectives of the Study
2.2.    Stakeholders
2.3.    Data Sources
2.3.1.    Primary Sources
2.3.2.    Secondary Sources
2.4.    Market Estimation
2.4.1.    Bottom-Up Approach
2.4.2.    Top-Down Approach
2.5.    Forecasting Methodology
3.    Executive Summary
4.    Global Oncolytic Virus Immunotherapy Market – Introduction
4.1.    What is Oncolytic Virus Immunotherapy
4.1.1.    Introduction
4.1.2.    Major Applications
4.2.    Industry Trends
4.3.    Competitive Intelligence
5.    Global Oncolytic Virus Immunotherapy Market Landscape
5.1.    Historical and Current Market Trends (2018-2023)
5.2.    Market Forecast (2024-2032)
6.    Global Oncolytic Virus Immunotherapy Market - Breakup by Virus Type
6.1.        Herpes Simplex Virus (HSV)
6.1.1.    Overview
6.1.2.    Historical and Current Market Trends (2018-2023)
6.1.3.    Market Forecast (2024-2032)
6.1.4.    Market Breakup by Application 
6.1.5.    Market Breakup by Route of Administration
6.1.6.    Market Breakup by End-User 
6.1.7.    Key Players 
6.2.        Adenovirus
6.2.1.    Overview
6.2.2.    Historical and Current Market Trends (2018-2023)
6.2.3.    Market Forecast (2024-2032)
6.2.4.    Market Breakup by Application 
6.2.5.    Market Breakup by Route of Administration
6.2.6.    Market Breakup by End-User 
6.2.7.    Key Players 
6.3.        Vaccinia Virus
6.3.1.    Overview
6.3.2.    Historical and Current Market Trends (2018-2023)
6.3.3.    Market Forecast (2024-2032)
6.3.4.    Market Breakup by Application 
6.3.5.    Market Breakup by Route of Administration
6.3.6.    Market Breakup by End-User 
6.3.7.    Key Players 
6.4.        Newcastle Disease Virus
6.4.1.    Overview
6.4.2.    Historical and Current Market Trends (2018-2023)
6.4.3.    Market Forecast (2024-2032)
6.4.4.    Market Breakup by Application 
6.4.5.    Market Breakup by Route of Administration
6.4.6.    Market Breakup by End-User 
6.4.7.    Key Players 
6.5.        Reovirus
6.5.1.    Overview
6.5.2.    Historical and Current Market Trends (2018-2023)
6.5.3.    Market Forecast (2024-2032)
6.5.4.    Market Breakup by Application 
6.5.5.    Market Breakup by Route of Administration
6.5.6.    Market Breakup by End-User 
6.5.7.    Key Players 
6.6.        Others
6.6.1.    Overview
6.6.2.    Historical and Current Market Trends (2018-2023)
6.6.3.    Market Forecast (2024-2032)
6.6.4.    Market Breakup by Application 
6.6.5.    Market Breakup by Route of Administration
6.6.6.    Market Breakup by End-User 
6.6.7.    Key Players 
6.7.    Attractive Investment Proposition by Virus Type
7.    Global Oncolytic Virus Immunotherapy Market - Breakup by Application
7.1.        Melanoma
7.1.1.    Overview
7.1.2.    Historical and Current Market Trends (2018-2023)
7.1.3.    Market Forecast (2024-2032)
7.1.4.    Market Breakup by Route of Administration 
7.1.5.    Market Breakup by Virus Type
7.1.6.    Market Breakup by End-User 
7.1.7.    Key Players 
7.2.        Breast Cancer
7.2.1.    Overview
7.2.2.    Historical and Current Market Trends (2018-2023)
7.2.3.    Market Forecast (2024-2032)
7.2.4.    Market Breakup by Route of Administration 
7.2.5.    Market Breakup by Virus Type
7.2.6.    Market Breakup by End-User 
7.2.7.    Key Players 
7.3.        Lung Cancer
7.3.1.    Overview
7.3.2.    Historical and Current Market Trends (2018-2023)
7.3.3.    Market Forecast (2024-2032)
7.3.4.    Market Breakup by Route of Administration 
7.3.5.    Market Breakup by Virus Type
7.3.6.    Market Breakup by End-User 
7.3.7.    Key Players 
7.4.        Ovarian Cancer
7.4.1.    Overview
7.4.2.    Historical and Current Market Trends (2018-2023)
7.4.3.    Market Forecast (2024-2032)
7.4.4.    Market Breakup by Route of Administration 
7.4.5.    Market Breakup by Virus Type
7.4.6.    Market Breakup by End-User 
7.4.7.    Key Players 
7.5.        Prostate Cancer
7.5.1.    Overview
7.5.2.    Historical and Current Market Trends (2018-2023)
7.5.3.    Market Forecast (2024-2032)
7.5.4.    Market Breakup by Route of Administration 
7.5.5.    Market Breakup by Virus Type
7.5.6.    Market Breakup by End-User 
7.5.7.    Key Players 
7.6.        Myeloma
7.6.1.    Overview
7.6.2.    Historical and Current Market Trends (2018-2023)
7.6.3.    Market Forecast (2024-2032)
7.6.4.    Market Breakup by Route of Administration 
7.6.5.    Market Breakup by Virus Type
7.6.6.    Market Breakup by End-User 
7.6.7.    Key Players 
7.7.        Bladder Cancer
7.7.1.    Overview
7.7.2.    Historical and Current Market Trends (2018-2023)
7.7.3.    Market Forecast (2024-2032)
7.7.4.    Market Breakup by Route of Administration 
7.7.5.    Market Breakup by Virus Type
7.7.6.    Market Breakup by End-User 
7.7.7.    Key Players 
7.8.    Colorectal Cancer
7.8.1.    Overview
7.8.2.    Historical and Current Market Trends (2018-2023)
7.8.3.    Market Forecast (2024-2032)
7.8.4.    Market Breakup by Route of Administration 
7.8.5.    Market Breakup by Virus Type
7.8.6.    Market Breakup by End-User 
7.8.7.    Key Players 
7.9.        Others
7.9.1.    Overview
7.9.2.    Historical and Current Market Trends (2018-2023)
7.9.3.    Market Forecast (2024-2032)
7.9.4.    Market Breakup by Route of Administration 
7.9.5.    Market Breakup by Virus Type
7.9.6.    Market Breakup by End-User 
7.9.7.    Key Players 
7.10.    Attractive Investment Proposition by Application
8.    Global Oncolytic Virus Immunotherapy Market - Breakup by End-User
8.1.        Hospitals & Clinics
8.1.1.    Overview
8.1.2.    Historical and Current Market Trends (2018-2023)
8.1.3.    Market Forecast (2024-2032)
8.1.4.    Market Breakup by Route of Administration 
8.1.5.    Market Breakup by Virus Type
8.1.6.    Market Breakup by Application
8.1.7.    Key Players 
8.2.        Cancer Research Institutes
8.2.1.    Overview
8.2.2.    Historical and Current Market Trends (2018-2023)
8.2.3.    Market Forecast (2024-2032)
8.2.4.    Market Breakup by Route of Administration 
8.2.5.    Market Breakup by Virus Type
8.2.6.    Market Breakup by Application
8.2.7.    Key Players 
8.3.        Ambulatory Surgical Centers
8.3.1.    Overview
8.3.2.    Historical and Current Market Trends (2018-2023)
8.3.3.    Market Forecast (2024-2032)
8.3.4.    Market Breakup by Route of Administration 
8.3.5.    Market Breakup by Virus Type
8.3.6.    Market Breakup by Application
8.3.7.    Key Players 
8.4.        Others
8.4.1.    Overview
8.4.2.    Historical and Current Market Trends (2018-2023)
8.4.3.    Market Forecast (2024-2032)
8.4.4.    Market Breakup by Route of Administration 
8.4.5.    Market Breakup by Virus Type
8.4.6.    Market Breakup by Application
8.4.7.    Key Players 
8.5.    Attractive Investment Proposition by End-User
9.    Global Oncolytic Virus Immunotherapy Market - Breakup by Route of Administration
9.1.        Intratumoral
9.1.1.    Overview
9.1.2.    Historical and Current Market Trends (2018-2023)
9.1.3.    Market Forecast (2024-2032)
9.1.4.    Market Breakup by End-User
9.1.5.    Market Breakup by Virus Type
9.1.6.    Market Breakup by Application
9.1.7.    Key Players
9.2.        Intravenous
9.2.1.    Overview
9.2.2.    Historical and Current Market Trends (2018-2023)
9.2.3.    Market Forecast (2024-2032)
9.2.4.    Market Breakup by End-User
9.2.5.    Market Breakup by Virus Type
9.2.6.    Market Breakup by Application
9.2.7.    Key Players
9.3.        Others
9.3.1.    Overview
9.3.2.    Historical and Current Market Trends (2018-2023)
9.3.3.    Market Forecast (2024-2032)
9.3.4.    Market Breakup by End-User
9.3.5.    Market Breakup by Virus Type
9.3.6.    Market Breakup by Application
9.3.7.    Key Players
9.4.    Attractive Investment Proposition by Route of Administration
10.    Global Oncolytic Virus Immunotherapy Market – Breakup by Region
10.1.    North America
10.1.1.        United States
10.1.1.1.    Market Drivers
10.1.1.2.    Historical and Current Market Trends (2018-2023)
10.1.1.3.    Market Breakup by Virus Type
10.1.1.4.    Market Breakup by Application
10.1.1.5.    Market Breakup by End-User
10.1.1.6.    Market Breakup by Route of Administration
10.1.1.7.    Key Players
10.1.1.8.    Market Forecast (2024-2032)
10.1.1.9.    Recent Investments
10.1.1.9.1.    Government Investments
10.1.1.9.2.    Private Investments
10.1.1.10.    Regulatory Approval Process
10.1.1.11.    Pricing Analysis 
10.1.2.        Canada
10.1.2.1.    Market Drivers
10.1.2.2.    Historical and Current Market Trends (2018-2023)
10.1.2.3.    Market Breakup by Virus Type
10.1.2.4.    Market Breakup by Application
10.1.2.5.    Market Breakup by End-User
10.1.2.6.    Market Breakup by Route of Administration
10.1.2.7.    Key Players
10.1.2.8.    Market Forecast (2024-2032)
10.1.2.9.    Recent Investments
10.1.2.9.1.    Government Investments
10.1.2.9.2.    Private Investments
10.1.2.10.    Regulatory Approval Process
10.1.2.11.    Pricing Analysis 
10.2.    Europe
10.2.1.        Germany
10.2.1.1.    Market Drivers
10.2.1.2.    Historical and Current Market Trends (2018-2023)
10.2.1.3.    Market Breakup by Virus Type
10.2.1.4.    Market Breakup by Application
10.2.1.5.    Market Breakup by End-User
10.2.1.6.    Market Breakup by Route of Administration
10.2.1.7.    Key Players
10.2.1.8.    Market Forecast (2024-2032)
10.2.1.9.    Recent Investments
10.2.1.9.1.    Government Investments
10.2.1.9.2.    Private Investments
10.2.1.10.    Regulatory Approval Process
10.2.1.11.    Pricing Analysis 
10.2.2.        France
10.2.2.1.    Market Drivers
10.2.2.2.    Historical and Current Market Trends (2018-2023)
10.2.2.3.    Market Breakup by Virus Type
10.2.2.4.    Market Breakup by Application
10.2.2.5.    Market Breakup by End-User
10.2.2.6.    Market Breakup by Route of Administration
10.2.2.7.    Key Players
10.2.2.8.    Market Forecast (2024-2032)
10.2.2.9.    Recent Investments
10.2.2.9.1.    Government Investments
10.2.2.9.2.    Private Investments
10.2.2.10.    Regulatory Approval Process
10.2.2.11.    Pricing Analysis 
10.2.3.        United Kingdom
10.2.3.1.    Market Drivers
10.2.3.2.    Historical and Current Market Trends (2018-2023)
10.2.3.3.    Market Breakup by Virus Type
10.2.3.4.    Market Breakup by Application
10.2.3.5.    Market Breakup by End-User
10.2.3.6.    Market Breakup by Route of Administration
10.2.3.7.    Key Players
10.2.3.8.    Market Forecast (2024-2032)
10.2.3.9.    Recent Investments
10.2.3.9.1.    Government Investments
10.2.3.9.2.    Private Investments
10.2.3.10.    Regulatory Approval Process
10.2.3.11.    Pricing Analysis 
10.2.4.        Italy
10.2.4.1.    Market Drivers
10.2.4.2.    Historical and Current Market Trends (2018-2023)
10.2.4.3.    Market Breakup by Virus Type
10.2.4.4.    Market Breakup by Application
10.2.4.5.    Market Breakup by End-User
10.2.4.6.    Market Breakup by Route of Administration
10.2.4.7.    Key Players
10.2.4.8.    Market Forecast (2024-2032)
10.2.4.9.    Recent Investments
10.2.4.9.1.    Government Investments
10.2.4.9.2.    Private Investments
10.2.4.10.    Regulatory Approval Process
10.2.4.11.    Pricing Analysis 
10.2.5.        Spain
10.2.5.1.    Market Drivers
10.2.5.2.    Historical and Current Market Trends (2018-2023)
10.2.5.3.    Market Breakup by Virus Type
10.2.5.4.    Market Breakup by Application
10.2.5.5.    Market Breakup by End-User
10.2.5.6.    Market Breakup by Route of Administration
10.2.5.7.    Key Players
10.2.5.8.    Market Forecast (2024-2032)
10.2.5.9.    Recent Investments
10.2.5.9.1.    Government Investments
10.2.5.9.2.    Private Investments
10.2.5.10.    Regulatory Approval Process
10.2.5.11.    Pricing Analysis 
10.2.6.        Russia
10.2.6.1.    Market Drivers
10.2.6.2.    Historical and Current Market Trends (2018-2023)
10.2.6.3.    Market Breakup by Virus Type
10.2.6.4.    Market Breakup by Application
10.2.6.5.    Market Breakup by End-User
10.2.6.6.    Market Breakup by Route of Administration
10.2.6.7.    Key Players
10.2.6.8.    Market Forecast (2024-2032)
10.2.6.9.    Recent Investments
10.2.6.9.1.    Government Investments
10.2.6.9.2.    Private Investments
10.2.6.10.    Regulatory Approval Process
10.2.6.11.    Pricing Analysis 
10.2.7.        Others
6.7.1.1.    Historical and Current Market Trends (2018-2023)
6.7.1.2.    Market Forecast (2024-2032)
10.3.    Asia Pacific 
10.3.1.        China
10.3.1.1.    Market Drivers
10.3.1.2.    Historical and Current Market Trends (2018-2023)
10.3.1.3.    Market Breakup by Virus Type
10.3.1.4.    Market Breakup by Application
10.3.1.5.    Market Breakup by End-User
10.3.1.6.    Market Breakup by Route of Administration
10.3.1.7.    Key Players
10.3.1.8.    Market Forecast (2024-2032)
10.3.1.9.    Recent Investments
10.3.1.9.1.    Government Investments
10.3.1.9.2.    Private Investments
10.3.1.10.    Regulatory Approval Process
10.3.1.11.    Pricing Analysis 
10.3.2.        Japan
10.3.2.1.    Market Drivers
10.3.2.2.    Historical and Current Market Trends (2018-2023)
10.3.2.3.    Market Breakup by Virus Type
10.3.2.4.    Market Breakup by Application
10.3.2.5.    Market Breakup by End-User
10.3.2.6.    Market Breakup by Route of Administration
10.3.2.7.    Key Players
10.3.2.8.    Market Forecast (2024-2032)
10.3.2.9.    Recent Investments
10.3.2.9.1.    Government Investments
10.3.2.9.2.    Private Investments
10.3.2.10.    Regulatory Approval Process
10.3.2.11.    Pricing Analysis 
10.3.3.        India
10.3.3.1.    Market Drivers
10.3.3.2.    Historical and Current Market Trends (2018-2023)
10.3.3.3.    Market Breakup by Virus Type
10.3.3.4.    Market Breakup by Application
10.3.3.5.    Market Breakup by End-User
10.3.3.6.    Market Breakup by Route of Administration
10.3.3.7.    Key Players
10.3.3.8.    Market Forecast (2024-2032)
10.3.3.9.    Recent Investments
10.3.3.9.1.    Government Investments
10.3.3.9.2.    Private Investments
10.3.3.10.    Regulatory Approval Process
10.3.3.11.    Pricing Analysis 
10.3.4.        South Korea
10.3.4.1.    Market Drivers
10.3.4.2.    Historical and Current Market Trends (2018-2023)
10.3.4.3.    Market Breakup by Virus Type
10.3.4.4.    Market Breakup by Application
10.3.4.5.    Market Breakup by End-User
10.3.4.6.    Market Breakup by Route of Administration
10.3.4.7.    Key Players
10.3.4.8.    Market Forecast (2024-2032)
10.3.4.9.    Recent Investments
10.3.4.9.1.    Government Investments
10.3.4.9.2.    Private Investments
10.3.4.10.    Regulatory Approval Process
10.3.4.11.    Pricing Analysis 
10.3.5.        Australia
10.3.5.1.    Market Drivers
10.3.5.2.    Historical and Current Market Trends (2018-2023)
10.3.5.3.    Market Breakup by Virus Type
10.3.5.4.    Market Breakup by Application
10.3.5.5.    Market Breakup by End-User
10.3.5.6.    Market Breakup by Route of Administration
10.3.5.7.    Key Players
10.3.5.8.    Market Forecast (2024-2032)
10.3.5.9.    Recent Investments
10.3.5.9.1.    Government Investments
10.3.5.9.2.    Private Investments
10.3.5.10.    Regulatory Approval Process
10.3.5.11.    Pricing Analysis 
10.3.6.        Indonesia
10.3.6.1.    Market Drivers
10.3.6.2.    Historical and Current Market Trends (2018-2023)
10.3.6.3.    Market Breakup by Virus Type
10.3.6.4.    Market Breakup by Application
10.3.6.5.    Market Breakup by End-User
10.3.6.6.    Market Breakup by Route of Administration
10.3.6.7.    Key Players
10.3.6.8.    Market Forecast (2024-2032)
10.3.6.9.    Recent Investments
10.3.6.9.1.    Government Investments
10.3.6.9.2.    Private Investments
10.3.6.10.    Regulatory Approval Process
10.3.6.11.    Pricing Analysis 
10.3.7.        Others
10.3.7.1.    Historical and Current Market Trends (2018-2023)
10.3.7.2.    Market Forecast (2024-2032)
10.4.    Latin America
10.4.1.        Brazil
10.4.1.1.    Market Drivers
10.4.1.2.    Historical and Current Market Trends (2018-2023)
10.4.1.3.    Market Breakup by Virus Type
10.4.1.4.    Market Breakup by Application
10.4.1.5.    Market Breakup by End-User
10.4.1.6.    Market Breakup by Route of Administration
10.4.1.7.    Key Players
10.4.1.8.    Market Forecast (2024-2032)
10.4.1.9.    Recent Investments
10.4.1.9.1.    Government Investments
10.4.1.9.2.    Private Investments
10.4.1.10.    Regulatory Approval Process
10.4.1.11.    Pricing Analysis 
10.4.2.        Mexico
10.4.2.1.    Market Drivers
10.4.2.2.    Historical and Current Market Trends (2018-2023)
10.4.2.3.    Market Breakup by Virus Type
10.4.2.4.    Market Breakup by Application
10.4.2.5.    Market Breakup by End-User
10.4.2.6.    Market Breakup by Route of Administration
10.4.2.7.    Key Players
10.4.2.8.    Market Forecast (2024-2032)
10.4.2.9.    Recent Investments
10.4.2.9.1.    Government Investments
10.4.2.9.2.    Private Investments
10.4.2.10.    Regulatory Approval Process
10.4.2.11.    Pricing Analysis 
10.4.3.        Others
10.4.3.1.    Historical and Current Market Trends (2018-2023)
10.4.3.2.    Market Forecast (2024-2032)
10.5.    Middle East
10.5.1.    Market Drivers
10.5.2.    Historical and Current Market Trends (2018-2023)
10.5.3.    Market Breakup by Virus Type
10.5.4.    Market Breakup by Application
10.5.5.    Market Breakup by End-User
10.5.6.    Market Breakup by Route of Administration
10.5.7.    Market Breakup by Country
10.5.8.    Key Players
10.5.9.    Market Forecast (2024-2032)
10.5.10.    Recent Investments
10.5.10.1.    Government Investments
10.5.10.2.    Private Investments
10.5.11.    Regulatory Approval Process
10.5.12.    Pricing Analysis
10.6.    Africa
10.6.1.    Market Drivers
10.6.2.    Historical and Current Market Trends (2018-2023)
10.6.3.    Market Breakup by Virus Type
10.6.4.    Market Breakup by Application
10.6.5.    Market Breakup by End-User
10.6.6.    Market Breakup by Route of Administration
10.6.7.    Market Breakup by Country
10.6.8.    Key Players
10.6.9.    Market Forecast (2024-2032)
10.6.10.    Recent Investments
10.6.10.1.    Government Investments
10.6.10.2.    Private Investments
10.6.11.    Regulatory Approval Process
10.6.12.    Pricing Analysis
10.7.    Attractive Investment Proposition by Region
11.    Technology Analysis 
11.1.    Overview of Different Technologies
11.2.    Technology wise Oncolytic Virus Immunotherapy Applications
11.3.    Time to Market for New Product
11.4.    Key Technology Trends
11.4.1.    Engineering of Oncolytic Viruses
11.4.2.     Biomarker Identification
11.4.3.    Combination Therapies
12.    Government Regulations and Strategies
13.    Global Oncolytic Virus Immunotherapy Market - Industry Analysis
13.1.    Drivers, Restraints, and Opportunities
13.1.1.    Overview
13.1.2.    Drivers
13.1.2.1.    Limitations of Traditional Therapies
13.1.2.2.    Rising Investments in R&D
13.1.2.3.    Technological Advancements
13.1.3.    Restraints
13.1.3.1.    Limited Understanding of Mechanisms
13.1.3.2.    Manufacturing Challenges
13.1.3.3.    Regulatory Hurdles
13.1.4.    Opportunities
13.1.4.1.    Market Expansion in Emerging Economies
13.1.4.2.    Expanded Clinical Trials
13.1.5.    Impact Analysis
13.2.    Porters Five Forces Analysis
13.2.1.    Overview
13.2.2.    Bargaining Power of Buyers
13.2.3.    Bargaining Power of Suppliers
13.2.4.    Degree of Competition
13.2.5.    Threat of New Entrants
13.2.6.    Threat of Substitutes
13.3.    Value Chain Analysis
14.    Global Oncolytic Virus Immunotherapy Market – Competitive Landscape
14.1.    Overview
14.2.    Market Structure
14.3.    Market Share by Key Players
14.4.    Market Player Positioning
14.5.    Top Winning Strategies
14.6.    Competitive Dashboard
14.7.    Company Evaluation Quadrant
15.    Profiles of Key Players
15.1.    Amgen Inc.
15.1.1.    Business Overview
15.1.2.    Products Offered
15.1.3.    Business Strategies
15.1.3.1.    Marketing Strategy
15.1.3.2.    Product Strategy
15.1.3.3.    Channel Strategy
15.1.4.    SWOT Analysis
15.1.5.    Major News and Events
15.2.    Creative Biolabs 
15.2.1.    Business Overview
15.2.2.    Products Offered
15.2.3.    Business Strategies
15.2.3.1.    Marketing Strategy
15.2.3.2.    Product Strategy
15.2.3.3.    Channel Strategy
15.2.4.    SWOT Analysis
15.2.5.    Major News and Events
15.3.    Daiichi Sankyo Company Limited
15.3.1.    Business Overview
15.3.2.    Products Offered
15.3.3.    Business Strategies
15.3.3.1.    Marketing Strategy
15.3.3.2.    Product Strategy
15.3.3.3.    Channel Strategy
15.3.4.    SWOT Analysis
15.3.5.    Major News and Events
15.4.    Genelux Corporation
15.4.1.    Business Overview
15.4.2.    Products Offered
15.4.3.    Business Strategies
15.4.3.1.    Marketing Strategy
15.4.3.2.    Product Strategy
15.4.3.3.    Channel Strategy
15.4.4.    Financials
15.4.5.    SWOT Analysis
15.4.6.    Major News and Events
15.5.    Oncorus Inc.
15.5.1.    Business Overview
15.5.2.    Products Offered
15.5.3.    Business Strategies
15.5.3.1.    Marketing Strategy
15.5.3.2.    Product Strategy
15.5.3.3.    Channel Strategy
15.5.4.    SWOT Analysis
15.5.5.    Major News and Events
15.6.    Replismune Inc.
15.6.1.    Business Overview
15.6.2.    Products Offered
15.6.3.    Business Strategies
15.6.3.1.    Marketing Strategy
15.6.3.2.    Product Strategy
15.6.3.3.    Channel Strategy
15.6.4.    SWOT Analysis
15.6.5.    Major News and Events
15.7.    Siga Technologies
15.7.1.    Business Overview
15.7.2.    Products Offered
15.7.3.    Business Strategies
15.7.3.1.    Marketing Strategy
15.7.3.2.    Product Strategy
15.7.3.3.    Channel Strategy
15.7.4.    SWOT Analysis
15.7.5.    Major News and Events
15.8.    Sorrento Therapeutics Inc.
15.8.1.    Business Overview
15.8.2.    Products Offered
15.8.3.    Business Strategies
15.8.3.1.    Marketing Strategy
15.8.3.2.    Product Strategy
15.8.3.3.    Channel Strategy
15.8.4.    Financials
15.8.5.    SWOT Analysis
15.8.6.    Major News and Events
15.9.    TILT Biotherapeutics
15.9.1.    Business Overview
15.9.2.    Products Offered
15.9.3.    Business Strategies
15.9.3.1.    Marketing Strategy
15.9.3.2.    Product Strategy
15.9.3.3.    Channel Strategy
15.9.4.    SWOT Analysis
15.9.5.    Major News and Events
15.10.    Viralytics Ltd.
15.10.1.    Business Overview
15.10.2.    Products Offered
15.10.3.    Business Strategies
15.10.3.1.    Marketing Strategy
15.10.3.2.    Product Strategy
15.10.3.3.    Channel Strategy
15.10.4.    SWOT Analysis
15.10.5.    Major News and Events
  
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

16.    Strategic Recommendations
17.    Appendix